CLINDAMYCIN PHOSPHATE
| Brand name | CLINDESSE |
|---|---|
| Active ingredient | CLINDAMYCIN PHOSPHATE |
| Strength | EQ 2% BASE |
| Dosage form | CREAM |
| Route | VAGINAL |
| Modality | Small molecule |
| FDA approval | November 2004 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9789057 | December 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.